Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer

NCT00802945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor
Breast Cancer

Interventions

DRUG: NKTR-102
DRUG: NKTR-102

Sponsor

Nektar Therapeutics